Literature DB >> 22855847

Acute leukemia arising after radioiodine treatment for thyroid cancer.

Marine Gilabert, Thomas Prebet.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22855847      PMCID： PMC3409803          DOI： 10.3324/haematol.2012.067454

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Ph+ acute lymphoblastic leukemia after iodine-131 treatment for thyroid cancer.

Authors:  N Piccirillo; F Sorà; L Laurenti; S Sica; P Chiusolo; G Leone
Journal:  Haematologica       Date:  1999-11       Impact factor: 9.941

Review 2.  Treatment of thyroid cancer.

Authors:  C J Edmonds
Journal:  Clin Endocrinol Metab       Date:  1979-03

3.  Therapy-related myeloid neoplasms following treatment with radioiodine.

Authors:  Thomas Schroeder; Andrea Kuendgen; Sabine Kayser; Nicolaus Kröger; Friederike Braulke; Uwe Platzbecker; Viola Klärner; Fabian Zohren; Detlef Haase; Michael Stadler; Richard Schlenk; Akos G Czibere; Ingmar Bruns; Roland Fenk; Norbert Gattermann; Rainer Haas; Guido Kobbe; Ulrich Germing
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

Review 4.  Acute leukemias after treatment with radioiodine for thyroid cancer.

Authors:  V Roldán Schilling; P Fernández Abellán; J R Domínguez Escribano; C Rivas González; E Mut Barberá; R Calatayud Cendra
Journal:  Haematologica       Date:  1998-08       Impact factor: 9.941

5.  Leukaemia incidence after iodine-131 exposure.

Authors:  P Hall; J D Boice; G Berg; G Bjelkengren; U B Ericsson; A Hallquist; M Lidberg; G Lundell; A Mattsson; J Tennvall
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

6.  Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.

Authors:  L Laurenti; P Salutari; S Sica; N Piccirillo; G Zini; M Zollino; G Leone
Journal:  Ann Hematol       Date:  1998-06       Impact factor: 3.673
  6 in total
  4 in total

1.  Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology.

Authors:  Bugra Ozer; Ugur Sezerman
Journal:  Funct Integr Genomics       Date:  2016-11-07       Impact factor: 3.410

Review 2.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

3.  Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.

Authors:  Remco J Molenaar; Surbhi Sidana; Tomas Radivoyevitch; Anjali S Advani; Aaron T Gerds; Hetty E Carraway; Dana Angelini; Matt Kalaycio; Aziz Nazha; David J Adelstein; Christian Nasr; Jaroslaw P Maciejewski; Navneet S Majhail; Mikkael A Sekeres; Sudipto Mukherjee
Journal:  J Clin Oncol       Date:  2017-12-18       Impact factor: 50.717

4.  Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131.

Authors:  Doina Piciu; Claudiu Pestean; Elena Barbus; Maria Iulia Larg; Andra Piciu
Journal:  Clujul Med       Date:  2016-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.